| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-106-2-209 |
| P698 | PubMed publication ID | 3541723 |
| P50 | author | Edward Stinson | Q55610560 |
| Philip E Oyer | Q110308949 | ||
| P2093 | author name string | I Potasman | |
| J S Remington | |||
| J C Baldwin | |||
| J M Hofflin | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cyclosporine | Q367700 |
| P304 | page(s) | 209-216 | |
| P577 | publication date | 1987-02-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids | |
| P478 | volume | 106 |
| Q44944424 | A Multivariate Analysis of Risk Factors for Cytomegalovirus Infection in Liver-Transplant Recipients |
| Q36124613 | A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole |
| Q70211141 | Acute rejection in human liver grafts: a comparative histologic study of cases maintained on azathioprine and prednisone versus cyclosporine A and low-dose steroids |
| Q39865375 | Antimicrobial strategies in the care of organ transplant recipients |
| Q71669425 | Aortic valve endocarditis in an acutely rejecting orthotopic heart transplant recipient |
| Q33719294 | Aspergillus infections in transplant recipients |
| Q67587058 | Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes |
| Q38232106 | Bacterial infections after liver transplantation |
| Q28281016 | Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies |
| Q28547946 | Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus |
| Q67505906 | Chronic intestinal pseudoobstruction in a patient with heart-lung transplant. Therapeutic effect of leuprolide acetate |
| Q38772748 | Complications after cardiac transplantation. The role of immunosuppression. |
| Q38204714 | Cyclosporine: a review and its specific use in liver transplantation |
| Q42409175 | Decreased incidence of viral infections in liver transplant recipients. Possible effects of FK506? |
| Q39519243 | Diagnosis of pulmonary infections in immunocompromised patients |
| Q53906467 | Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections. |
| Q37092200 | Emergence of new pathogens as a function of changes in host susceptibility |
| Q33926071 | Five-years surveillance of invasive aspergillosis in a university hospital |
| Q34294909 | Fluconazole in transplant recipients: options and limitations |
| Q34764824 | Hospital-acquired legionellosis: solutions for a preventable infection |
| Q35649657 | Host defence to pulmonary mycosis |
| Q28345946 | In vitro and in vivo activities of syn2836, syn2869, syn2903, and syn2921: new series of triazole antifungal agents |
| Q37625139 | In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients |
| Q34302075 | Infections after liver transplantation. An analysis of 101 consecutive cases |
| Q68035357 | Infections in orthotopic heart transplant patients at the Ochsner Medical Institutions |
| Q35376486 | Infections in solid-organ transplant recipients |
| Q34294929 | Infections of the central nervous system in transplant recipients |
| Q72387145 | Infectious complications in 100 consecutive heart transplant recipients |
| Q34305102 | Infectious complications of solid organ transplantations |
| Q44457172 | Infective dyspepsia in a heart transplant recipient |
| Q40440616 | Invasive aspergillosis in systemic lupus erythematosus |
| Q44007394 | Invasive fungal infections in pediatric heart transplant recipients: Incidence, risk factors, and outcomes |
| Q42206624 | Invasive pulmonary aspergillosis in heart transplant recipients: two radiologic patterns with a different prognosis |
| Q47109298 | Legionella pneumonia due to non-Legionella pneumophila serogroup 1: usefulness of the six-point scoring system. |
| Q40757359 | Legionellosis in heart transplant recipients |
| Q34487838 | Legionnaires' disease |
| Q47755745 | Leukemia Inhibitory Factor-Loaded Nanoparticles with Enhanced Cytokine Metabolic Stability and Anti-Inflammatory Activity |
| Q68349311 | Life in the allogeneic environment after lung transplantation |
| Q68171965 | Mediastinitis due to Nocardia asteroides after cardiac transplantation |
| Q41317685 | Multidrug transporter p‐glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: Modulation with differentiation stage and during aging |
| Q35642204 | Newer combination antifungal therapies for invasive aspergillosis. |
| Q77772396 | Nocardia infection in lung transplant recipients |
| Q58487173 | Nosocomial legionellosis in three heart-lung transplant patients: Case reports and environmental observations |
| Q54368794 | Opportunistic upper gastrointestinal infection in transplant recipients |
| Q37591474 | Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial. |
| Q37898546 | Oral administration of cyclosporin does not prevent expansion of antigen-specific, gut-associated, and spleen lymphocyte populations during Chlamydia trachomatis proctitis in nonhuman primates |
| Q77724889 | Outcome of liver transplantation after acute rejection and sepsis |
| Q35162881 | Outcomes of Pneumocystis jiroveci pneumonia infections in pediatric heart transplant recipients |
| Q57462984 | Overlapping Roles for IL-36 Cytokines in Protective Host Defense against Murine Pneumonia |
| Q34363242 | Paracoccidioidomycosis: an update |
| Q26751428 | Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients |
| Q40720247 | Pneumocystis carinii pneumonia in heart transplant recipients |
| Q69408213 | Recurrent Listeria monocytogenes meningitis in a heart transplant recipient |
| Q41642531 | Rejection, herpesvirus infection, and Ki-67 Expression in endomyocardial biopsy specimens from heart transplant recipients |
| Q38458270 | Sepsis in the severely immunocompromised patient |
| Q79869029 | Severe obstruction of the left main coronary artery by mycotic aortic psuedoaneurysm following orthotopic heart transplantation |
| Q71518992 | Single-stage treatment of sternal wound complications in heart transplant recipients in whom pectoralis major myocutaneous advancement flaps were used |
| Q35528638 | Strategies for prevention of infection after cardiac transplantation |
| Q35101827 | Successful management of disseminated Nocardia transvalensis infection in a heart transplant recipient after development of sulfonamide resistance: case report and review |
| Q42160869 | Successful management of sequential pulmonary infections in a cardiac transplant recipient |
| Q80502436 | Successful treatment of Nocardia nova bacteremia and multilobar pneumonia with clarithromycin in a heart transplant patient |
| Q74748333 | The epidemiology and prevention of invasive aspergillosis |
| Q44282950 | The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants |
| Q36641751 | The medically important aerobic actinomycetes: epidemiology and microbiology |
| Q36829316 | The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements |
| Q41648638 | Thirty years of cardiac transplantation at Stanford university |
| Q78423873 | Transdiaphragmatic hernia 1 year after heart transplantation following implantable LVAD |
| Q37644333 | Urinary tract infection in the impaired host |
| Q81193460 | [Epidemiology of and risk factors for invasive aspergillosis in nonneutropenic patients] |
| Q72307098 | [Surgical antibiotic prophylaxis in a patient undergoing immunosuppressive treatment] |
Search more.